nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A novel G168X mutation and a recurrent 730-731delCT mutation of the porphobilinogen deaminase gene in Japanese patients with acute intermittent porphyria
|
Susa, Shinji |
|
2013 |
51 |
2 |
p. 130-131 2 p. |
artikel |
2 |
Association between the genetic polymorphisms of glutathione S-transferase (GSTM1 and GSTT1) and the clinical manifestations in sickle cell anemia
|
de Oliveira Filho, Romério Alencar |
|
2013 |
51 |
2 |
p. 76-79 4 p. |
artikel |
3 |
Corrigendum to “Expression of four major WT1 splicing variants in acute and chronic myeloid leukemia patients analyzed by newly developed four real-time RT PCRs” [Blood Cells Mol. Dis. 49 (1) (2012) 41–47]
|
Lopotová, Tereza |
|
2013 |
51 |
2 |
p. 132- 1 p. |
artikel |
4 |
Deferiprone-induced seizures in a patient with β-thalassemia major
|
Mallat, Naji S. |
|
2013 |
51 |
2 |
p. 94-95 2 p. |
artikel |
5 |
Editorial Board
|
|
|
2013 |
51 |
2 |
p. IFC- 1 p. |
artikel |
6 |
Enhanced erythroid cell differentiation in hypoxic condition is in part contributed by miR-210
|
Sarakul, Orawan |
|
2013 |
51 |
2 |
p. 98-103 6 p. |
artikel |
7 |
Erythroid transcription factor EKLF/KLF1 mutation causing congenital dyserythropoietic anemia type IV in a patient of Taiwanese origin: Review of all reported cases and development of a clinical diagnostic paradigm
|
Jaffray, Julie A. |
|
2013 |
51 |
2 |
p. 71-75 5 p. |
artikel |
8 |
Long-term treatment with deferiprone enhances left ventricular ejection function when compared to deferoxamine in patients with thalassemia major
|
Filosa, Aldo |
|
2013 |
51 |
2 |
p. 85-88 4 p. |
artikel |
9 |
Miglustat therapy in type 1 Gaucher disease: Clinical and safety outcomes in a multicenter retrospective cohort study
|
Kuter, David J. |
|
2013 |
51 |
2 |
p. 116-124 9 p. |
artikel |
10 |
Molecular and hematological studies in a large cohort of α0-thalassemia in northeast Thailand: Data from a single referral center
|
Chaibunruang, Attawut |
|
2013 |
51 |
2 |
p. 89-93 5 p. |
artikel |
11 |
Neurotoxicity of the anticoagulant-selective E149A-activated protein C variant after focal ischemic stroke in mice
|
Wang, Yaoming |
|
2013 |
51 |
2 |
p. 104-108 5 p. |
artikel |
12 |
The influence of the BCL11A polymorphism on the phenotype of patients with beta thalassemia could be affected by the beta globin locus control region and/or the Xmn1-HBG2 genotypic background
|
Neishabury, Maryam |
|
2013 |
51 |
2 |
p. 80-84 5 p. |
artikel |
13 |
Transgenic mice expressing human glucocerebrosidase variants: Utility for the study of Gaucher disease
|
Sanders, Angela |
|
2013 |
51 |
2 |
p. 109-115 7 p. |
artikel |
14 |
Twice daily deferasirox significantly improves clinical efficacy in transfusion dependent thalassaemias who were inadequate responders to standard once daily dose
|
Pongtanakul, Bunchoo |
|
2013 |
51 |
2 |
p. 96-97 2 p. |
artikel |
15 |
X-linked thrombocytopenia in a female with a complex familial pattern of X-chromosome inactivation
|
Daza-Cajigal, V. |
|
2013 |
51 |
2 |
p. 125-129 5 p. |
artikel |